Search

Your search keyword '"Crestani, Bruno"' showing total 834 results

Search Constraints

Start Over You searched for: Author "Crestani, Bruno" Remove constraint Author: "Crestani, Bruno" Language english Remove constraint Language: english
834 results on '"Crestani, Bruno"'

Search Results

2. New Dominant-Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130-Dependent Hyper-IgE Syndrome

3. Clinical characteristics and outcomes of respiratory syncytial virus-associated ARF in immunocompetent patients: A seven-year experience at a tertiary hospital in France

9. Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 Pneumonia

10. Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

11. Human inherited CCR2 deficiency underlies progressive polycystic lung disease

13. 2022 Update of indications and contraindications for lung transplantation in France

14. French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis – 2021 update. Full-length version

15. Correction to: New Dominant‑Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130‑Dependent Hyper‑IgE Syndrome

17. Updates on the controversial roles of regulatory lymphoid cells in idiopathic pulmonary fibrosis.

18. Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative

19. Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial

20. Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial

21. Treatment of Idiopathic Pulmonary Fibrosis with Capsule or Tablet Formulations of Pirfenidone in the Real-Life French RaDiCo-ILD Cohort

22. Low income and outcome in idiopathic pulmonary fibrosis: An association to uncover

23. Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

26. Chronic interstitial lung disease associated with systemic lupus erythematosus: A multicentric study of 89 cases.

27. COVID-19 PBMCs are doubly harmful, through LDN-mediated lung epithelial damage and monocytic impaired responsiveness to live Pseudomonas aeruginosa exposure.

28. Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors.

29. Rheumatoid arthritis and idiopathic pulmonary fibrosis: a bidirectional Mendelian randomisation study.

32. A Systematically Derived Exposure Assessment Instrument for Chronic Hypersensitivity Pneumonitis

33. Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

37. Breaking barriers: holistic assessment of ability to work in patients with sarcoidosis

42. Impact of Air Pollution and MUC5B Genotype on Survival in Idiopathic Pulmonary Fibrosis.

44. Interleukin-8 release by endothelial colony-forming cells isolated from idiopathic pulmonary fibrosis patients might contribute to their pathogenicity

46. Heterogeneity of lung disease associated with NK2 homeobox 1 mutations

48. Pilot experience of multidisciplinary team discussion dedicated to inherited pulmonary fibrosis

50. Short peripheral blood leukocyte telomere length in rheumatoid arthritis- interstitial lung disease.

Catalog

Books, media, physical & digital resources